RPS Booklet

767 views
679 views

Published on

Published in: Health & Medicine, Education
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
767
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

RPS Booklet

  1. 1. RPS Bylaws RPS Application Form Information for Members Awards Bestowed by the RPS Nephropathology Training Programs RPS Officers Presentations and Speakers at RPS Sponsored Scientific and Educational Sessions The most important tool of the Communication and Publications Committee of the Renal Pathology Society is the RPS web-site. The objective of the site is to facilitate communication between the members of the RPS, and between the RPS other societies. To this effect, the web-site includes the directory of members with data regarding their areas of research interest - "yellow pages". Collaborative studies and surveys are posted, to ensure continuous availability. Visit the web-site at http://www.renalpathsoc.org/ and learn more about the history of the society, the upcoming international meetings or courses, the opportunities available, the composition of the committees. The Committee is pleased to have available two further services: upon request, electronic messages can be disseminated to all the members (contact ssmith1@tulane.edu) and an electronic discussion group for renal pathology is available at NEPHNPT (contact Kim.Solez@ualberta.ca). Suzanne Meleg-Smith, MD Chair, Communication and Publications Committee
  2. 2. delayed until those issues can be discussed at the business meeting. The membership will be notified at the next business meeting of the Society of all new members accepted and their corresponding affiliations. BYLAWS OF Article IV RENAL PATHOLOGY SOCIETY, INC Officers: (Incorporation version, 3/96, A. Elected Officers: modified 11/97, 3/03, 4/04, 11/04) 1. President Term of office is one year. If the President vacates the office prematurely, the Article I Vice-President succeeds. A President may not Name: succeed him/herself in office. Renal Pathology Society, Inc. 2. Vice-President/President-Elect Vice-President Article II serves one year as Vice-President and shall Objectives: succeed as President. If this office is vacated The objectives of the Society are to disseminate and prematurely, the senior Councillor shall to increase knowledge about the pathology and become Vice-President. pathophysiology of the kidney, and to encourage the 3. Secretary-Treasurer Term of office is three development of renal pathology as a subspecialty. years, with a maximum of two terms. If this Article III office is vacated prematurely, the President Membership: shall appoint a replacement to serve until the A. Categories of Membership: next election of officers. 1. Regular Member Any holder of a MD, PhD, 4. Councillors Three councillors serve staggered DVM, or equivalent degree with demonstrated terms of three years each. If this office is interest and involvement in the field of renal vacated prematurely, the President shall pathology as determined by the Membership appoint a replacement to serve until the next Committee using criteria agreed upon by the election of officers. Board of Directors. B. Election of Officers: 2. Emeritus Member A member over age 65 may Any Society Regular Member is eligible to hold become emeritus by requesting this status, in office. Nomination shall be recommended by a writing, to the Secretary-Treasurer. Nominating Committee and may be offered from the 3. Junior Member any holder of a MD, PhD, floor by any Regular Member. Election shall be by DVM, or equivalent degree with demonstrated mail ballot. A majority vote of the responding interest in the field of renal pathology as members is required to elect an officer. evidenced by enrollment in a renal pathology C. Duties of Each Officer: training program or research at the resident or 1. President The President shall be the principal fellow level. executive officer of the Society. He/she shall B. Membership Committee: Three members appointed preside at all meetings, serve as Chair of the by the President shall serve staggered terms of three Board of Directors, and take responsibility as a years each. The Chair shall be the most senior representative of the Society. The President member. officially receives donations, bequests, or gifts C. Conferring of Membership: An application form to the Society on behalf of the Society. The (designed by the Membership Committee and President shall appoint all standing committees, approved by the Board of Directors) must be sent to and replacements for Vice-Presidents and the Secretary-Treasurer. The Membership Councillors who vacate their offices Committee will review the applications and prematurely. Ad hoc committees shall be recommend approval or disapproval by the Board of appointed by the President. Before finishing Directors. All members of the Renal Pathology Club his/her term, the President shall select a shall automatically become Regular Members councillor who must be approved by the following approval of the Bylaws. However, to membership by a majority vote. The Board of retain their Membership, these Charter Members Directors may be called upon to make must submit a Membership application form within 3 recommendations for the new councillor. months after receiving the form from the 2. Vice-President The Vice-President, in absence Membership Committee. Membership can be or incapacity of the President, shall perform the terminated by written resignation addressed to the duties of the President. Further, the Vice- President or Secretary-Treasurer. President shall serve on the Board of Directors. D. Rights of Members: Only Regular Members have the 3. Secretary-Treasurer The Secretary-Treasurer right to hold office and to vote. Each Regular shall keep minutes of the Annual and Board of Member has one vote. All Members have the right to Directors meetings, distribute notices to attend the scientific sessions, and to participate in members of Society, keep custody of deliberations and discussions at the business documents of Society (including mortgages, meetings. No Member shall use the name, property, deeds, and contracts that the Board of Directors or the organization of the Society for personal has approved), serve on the Board of Directors, benefit. Only currently elected officers shall receive membership applications and dues, represent the Society in official business. keep records of financial documents for E. New members will be approved continuously governmental agencies, banks or other financial throughout the year as new applications are submitted institutions with approval of the President for to the Membership Committee for consideration. expenses used solely for the Society. All such The chair and two members will decide whether the disbursements shall be reported at the Annual applicant can be approved as a member. Only in the Meeting. case of questions or problems will the application be 4. Compensation The Officers shall not be paid for their services and shall not receive any
  3. 3. financial benefits from their service as officers of Nephrology Meeting, and U.S. and Canadian of the Society. Academy of Pathology Meeting. The time and place Article V will be determined by the Board of Directors. Board of Directors: B. Business Meeting This meeting shall be held A. The Board of Directors shall consist of the current annually during the ASN meeting. A quorum (i.e. officers (i.e., President, Vice-President, Secretary- 1/5 of total or 20 Regular Members) must be present Treasurer, and three Councillors), the past President, to conduct business, but the scientific meeting may and Chairmen of the standing committees (i.e., the proceed in the absence of a quorum. chairmen of the Auditing [Secretary-Treasurer], C. Board of Directors Meeting This meeting shall be Program, Education and Scientific, Nominating and held twice annually during the USCAP and ASN Awards, Membership, Training Programs, meetings. Communications and Publications, and Research D. Special Meetings These may be called as deemed Committees). necessary by the Board of Directors or President. B. The Board of Directors shall: 1. Represent the Society in official business. 2. Carry out the directives and policies approved Article VIII by the membership. Order of Business at the Annual Business Meeting: 3. Organize and coordinate all meetings of the A. Determination of quorum Society, in collaboration with the Education B. Approval of the agenda and Scientific Meeting Committee. C. Previous meeting minutes: Secretary-Treasurer 4. Exert leadership in the development and D. Financial report: Secretary-Treasurer implementation of scientific programs E. Reports of Committees according to the above stated objectives of F. Old business Society. G. New business 5. Deal specifically with matters related to the H. Announcement of new members and officers incorporation of Society. I. Adjournment Article VI Article IX Standing Committees (to be appointed by President): Dues, Fees, and Compensation: A. Program Committee The Committee shall be A. Dues The annual dues shall be determined each year responsible for the design, organization and conduct by the Board of Directors. of the scientific meeting sponsored by the Renal Junior members are not required to pay Society’s Pathology Society at the United States-Canadian dues while in training. Academy of Pathology and American Society of B. Arrears Any member in arrears of dues for more Nephrology and shall report to the Board of than two years, failing satisfactory explanation, shall Directors. The Committee shall be composed of no be dropped from membership. Such members may less than three members. be reinstated on approval of the Membership B. Education and Scientific Committee This Committee Committee. shall be responsible jointly with the Board of C. Compensation No Society officer shall receive Directors for design, organization and conduct and compensation for his/her services as such. The Board other education efforts of the Society, and shall report of Directors, acting by majority vote, may authorize to the Board of Directors. The Committee shall be or ratify the payment to any officer or member of composed of no less than three members. reasonable compensation for expenses incurred on C. Membership Committee (See Article III.) behalf of the Society in any capacity deemed D. Nominating and Awards Committee This Committee necessary or advisable and in the best interest of the shall consist of three members. The past-President, Society. acting as chair, and two additional acting Regular Article X Members appointed by the current President. It shall Amendments: be responsible for nominating new officers and Amendments to the Bylaws may be suggested in writing to selecting recipients for awards. the Secretary-Treasurer by any Regular Member at least E. Training Programs Committee This Committee shall two months prior to the Annual Business Meeting. If encourage broader availability of training approved by the Board of Directors, this amendment needs opportunities in renal pathology and help to upgrade to be accepted by a two-thirds majority mail vote of the their quality. Committee activities shall include Regular Members. collection and dissemination of information about Article XI training programs and identification and development Limitations and Dissolution: of sources of support for trainees. A. Limitations on Earnings No part of the net earnings F. Auditing Committee This Committee shall consist of of the Society shall inure to the benefit of, or be three members. The Secretary-Treasurer, acting as distributable to its members, trustees, directors, chair, and two additional Regular Members appointed officers, or other private persons except that the by the current president. It shall be responsible for an Society shall be authorized and empowered to pay annual audit of Society financial affairs. reasonable compensation for services rendered and to G. Communications and Publications Committee This make payments and distributions in furtherance of the Committee shall oversee development of and monitor Society's purposes as set forth in Article II. the Society presence on online computer resources B. Activities Not Permitted No substantial part of the and print publications of the Society. activities of the Society shall be the carrying on of H. Research Committee This Committee shall plan and propaganda, or otherwise attempting to influence implement collaborative research projects involving legislation, and the corporations shall not participate the members of the RPS. in or intervene in (including the publication or Article VII distribution of statements) of any political campaign Meetings: on behalf of any candidate for public office. A. Scientific Meetings These meetings shall be held Notwithstanding any other provision of these bylaws, twice annually during the annual American Society the corporation shall not carry on any other activity
  4. 4. not permitted to be carried on (a) by a corporation exempt from federal income tax under Section 501 (c) (3) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law) or (b) by a corporation, contributions to which are a deductible under Section 170 (c) (2) of the Internal Revenue Code of 1986 (or the corresponding provision of any future United States Internal Revenue Law). C. Dissolution Upon dissolution of the Society, the assets of the Society shall, after all its liabilities and obligations have been discharged or adequate provision made therefore, be distributed to the National Kidney Foundation if it is still in existence and is an exempt organization under Section 510 (c) (3) of the Internal Revenue Code or any successor section. If the National Kidney Foundation is not so qualified at the time of the dissolution of the corporation, the net assets shall be distributed to a corporation that is exempt under Section 501 (c) (3) of the Internal Revenue Code of 1986 or any successor section which is organized for purposes similar to those set out in Article II of these bylaws.
  5. 5. RENAL PATHOLOGY SOCIETY APPLICATION FORM The Renal Pathology Society is a nonprofit organization committed to increasing and disseminating knowledge about the pathology and pathophysiology of the kidney. Membership is open to any MD, PhD, DVM, or equivalent degree holder who has demonstrated accomplishments in nephropathology as determined by the Membership Committee under the direction of the Executive Committee Please type or print. 1. Membership requires fulfillment of at least one of the following criteria: Criterion 1: Publication of at least one peer-reviewed article in the field of nephropathology. Criterion 2: Completion of a minimum of six months research or clinical training in nephropathology, e.g. during residency or postdoctoral fellowship. Criterion 3: Extensive clinical experience with the diagnostic pathologic evaluation of renal diseases Criterion 4: Extensive research experience on the pathology, pathophysiology, or pathogenesis of renal diseases. Indicate by number which of these criteria you fulfill _______________ 2. Fill in the following information: Candidate Name Position Department Institution Street Address City, State, Country, Mailing Code Telephone FAX E-mail Address I certify that the information supplied is correct, and hold the Renal Pathology Society and its members free from any damage or complaint resulting from any action they may take in connection with this application. Signature of Applicant Date Print name of RPS member Signature of RPS Member Date who is sponsoring applicant. 3. Mail this form together with your current curriculum vitae to the Renal Pathology Society Chairman of the Membership Committee.
  6. 6. Renal Pathology Society Awards YOUNG INVESTIGATOR AWARD The Renal Pathology Society Young Investigator Award was established to recognize and encourage excellence in the area of renal pathology in accordance with the goals of the Society. The recipients of the award are selected from those nominated based on the contents of abstracts that they have submitted as first author to the annual meeting of the ASN or USCAP. The awards, in the amount of $500 (US), are presented at the ASN and USCAP Meetings. Candidates must be nominated by a member of the Renal Pathology Society. The RPS member does not need to be a co-author of the submitted abstract but, if not, he or she should be from the same institution as the nominee. The research must have been carried out, while the candidate was a trainee (e.g., medical student, resident, fellow, graduate student) and not a faculty member. Nominations should be submitted to the Chair of the Nominating and Award Committee. Winners of the Renal Pathology Society Young Investigators Award Awarded at the Recipient Title Sponsor Expression of TIA-1, a 1995 USCAP Shane Meehan, M.D. cytoxic I cell protein in R. B. Colvin renal allograft rejection. Early hypoxia induced loss of Na, K-ATpase polarity in proximal tubules is 1996 USCAP Hugh B. Carey, M.D. M. Kashgarian associated with specific calpain regulated fodrin processing. Modulation of plasminogen activator inhibitor-1 (PAI-1) in vivo: A new mechanism 1996 ASN Tsuyoshi Oikawa, M.D. A. Fogo for the anti-fibrotic effect of renin-angiotensin inhibition. In vitro AL-amyloid formation by human 1997 USCAP Jorge Isaac, M.D. G. Herrera mesangial cells (HMCs) is attenuated by chloroquine Variable region gene selection in murine anti- 1997 ASN Hitendra S. Jethwa J.C. Jennette myeloperoxidase (MPO) autoantibodies 1998 USCAP No award given Expression of chemokines 1999 USCAP Peter Heeringa in murine crescentic J.C. Jennette glomerulonephritis 1999 ASN No award given Regression of glomerulosclerosis in aging by angiotensin II A. Fogo 2000 USCAP Li-jun Ma Type 1 receptor antagonist (AIIRA) is linked to inhibition of plasminogen activator inhibitor-1 (PAI-1) 2000 ASN No award given Blunted TGF-beta and ECM mRNA response during early acute 2001 ASN Michael Eikmans, Ph.D. J. Bruijn rejection predicts for late development of chronic rejection 2003 USCAP Adrian Suarez, M.D. Altered gene transcript H. Liapis profiles in congenitally
  7. 7. obstructed human kidneys. Absence of integrin αvβ6 decreases interstitial A. Fogo 2004 USCAP Hai-Chun Yang fibrosis but worsens glomerulosclerosis in remnant kidney mice Thymosin β4 is a marker or possibly even a 2005 USCAP Xiubin Liang contributor to A. Fogo glomerulosclerosis THE JACOB CHURG AWARD The Jacob Churg Award, is presented annually at the USCAP meeting to an individual who has made major contributions to the field of nephropathology. The monetary component of the award is supported by a fund established by Barnert Hospital where Dr. Churg spent a substantial portion of his career on occasion of his retirement in 1996. Awardees are nominated by RPS members and selected from the nominations by the RPS Nominations and Awards Committee. Nominations, which should include a letter from the nominator and a C.V. of the nominee, should be sent to the Chair of this Committee. The First Jacob Churg Award was presented to J. Charles Jennette, M.D. at the 1997 USCAP Meeting in Orlando, FL The Second Jacob Churg Award was presented to Robert B. Colvin, M.D. at the 1998 USCAP Meeting in Boston, MA. The Third Jacob Churg Award was presented to Agnes Fogo, M.D. at the 1999 USCAP Meeting in San Francisco, CA. The Fourth Jacob Churg Award was presented to Vivette D’Agati, M.D. at the 2000 USCAP Meeting in New Orleans, LA. The Fifth Jacob Churg Award was presented to Melvin M. Schwartz, M.D. at the 2001 USCAP Meeting in Atlanta, GA. The Sixth Jacob Churg Award was presented to Fred Silva, M.D. at the 2002 USCAP Meeting in Chicago, IL. The Seventh Jacob Churg Award was presented to Charles Alpers, M.D. at the 2003 USCAP Meeting in Washington, DC. The Eighth Jacob Churg Award was presented to Michael Kashgarian, M.D. at the 2004 USCAP Meeting in Vancouver, Canada. The Ninth Jacob Churg Award was presented to Arthur Cohen, M.D. at the 2005 USCAP Meeting in San Antonio, TX.
  8. 8. Renal Pathology Fellowships and Program Directors Program Site: Program Director: Mailing Address: Phone: FAX: Brigham and Helmut G. Rennke, M.D. Department of Pathology Phone: (617) 732-6518 Women's Hospital Brigham & Women's Hospital FAX: (617) 227-9015 75 Francis Street Boston, MA 02115 College of Vivette D'Agati, M.D. Renal Pathology Laboratory Phone: (212) 305-6269 Physicians and VC14-219 FAX: (212) 305-5498 Surgeons College of Physicians & Surgeons of Columbia University 630 W 168th Street New York, NY 10032 Cedars-Sinai Arthur H. Cohen, M.D. Department of Pathology Phone: (310) 855-6621 Medical Center Cedars-Sinai Medical Center FAX: (310) 967-0122 8700 Beverly Blvd Los Angeles, CA 90048 Barnert Hospital, Surya Seshan, M.D. Department of Pathology Phone: (201) 977-6770 NJ Barnert Hospital FAX: (201) 977-6812 680 Broadway Paterson, NJ 07514 University of Kim Solez, M.D. Department of Pathology Phone: (403) 492-2252 Alberta University of Alberta FAX: (403) 492-2253 5B4.02 Walter Mackenzie Centre Edmonton, Alberta Canada T6G 2R7 University of North Volker Nickeleit, M.D Department of Pathology Phone: (919) 966-2421 Carolina at Chapel University of North Carolina FAX: (919) 966-4542 Hill School of Medicine Chapel Hill, NC 27599-7525 University of Charles E. Alpers, M.D. Division of Hospital Pathology Phone: (206) 548-6409 Washington University of Washington FAX: (206) 548-4928 Medical Center RC72, Rm BB 210J Seattle, WA 98195 Vanderbilt Agnes Fogo, M.D. Department of Pathology Phone: (615) 322-2102 University Vanderbilt University FAX: (615) 322-3988 Medical Center, MCN C-3310 21st Avenue, S Nashville, TN 37232 Yale University Michael Kashgarian, M.D. Department of Pathology Phone: (203) 785-275 Yale University School of Medicine FAX: (203) 785-3348 POB 208023 New Haven, CT 0650-8023 Louisiana State Guillermo Herrera, M.D. Department of Pathology Phone: (318) 675-4557 University Health LSUHSC - Shreveport FAX: (318) 675-7662 Sciences Center, 1501 Kings Highway Shreveport Shreveport, LA 71130-3932 Johns Hopkins Lorraine C. Racusen, M.D. Department of Pathology Phone: (410) 955-343 Medical Institutions 600 North Wolf Street FAX: (410) 614-9011 Baltimore, MD 21205 Members who have information about training programs not listed here are encouraged to contact the Chair of the Training Programs Committee.
  9. 9. RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS + 1993 1994 1995 1996 1997 1998 Officers * : President: Gloria Gallo Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen Robert Colvin Vice-President: Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen Robert Colvin Seymour Rosen Secretary/Treasurer: Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Councillors: Arthur Cohen Arthur Cohen Arthur Cohen Robert Colvin Seymour Rosen Charles Alpers Vivette D'Agati Vivette D'Agati Robert Colvin Seymour Rosen Charles Alpers Melvin Schwartz Fred Silva Robert Colvin Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo Committees * : Membership: Samy Iskandar Regina Verani Agnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz Regina Verani Agnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz Walter Richardson Agnes Fogo Stephen Bonsib Allan Katz Melvin Schwartz Walter Richardson Alex Magil Nominating Jay Bernstein Gloria Gallo Michael Kashgarian Fred Silva Vivette D'Agati Arthur Cohen & Awards: Benjamin Spargo Manjeri Venkatachalam Melvin Schwartz Surya Venkataseshan Seymour Rosen Mark Haas Jean Olson Helmut Rennke Victoriano Pardo Mark Weiss Agnes Fogo Charles Alpers Education Robert Colvin Charles Alpers Arthur Cohen Agnes Fogo Cynthia Nast Helmut Rennke & Scientific: Helmut Rennke Lorraine Racusen Vivette D'Agati Charles Alpers Michael Kashgarian Lorraine Racusen Charles Alpers Mark Haas Jean Olson Helmut Rennke Lillian Gaber Seymour Rosen Training Fred Silva Fred Silva Cynthia Nast Michael Kashgarian Guillermo Herrera Guillermo Herrera Programs: Gary Striker Gary Striker Helmut Rennke Liliane Striker Tibor Nadasdy Terry Oberley Seymour Rosen Arthur Cohen Tibor Nadasdy Robert Colvin Regina Verani Volker Nickeleit Auditing: Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Charles Jennette Mark Weiss Gary Hill Guillermo Herrera Luan Truong Praveen Chander Jean Olson Cynthia Nast Agnes Fogo Dinyar Bhathena Dae Un Kim Isaac Stillman Anthony Nicastri Communications & Cynthia Nast Cynthia Nast Samy Iskandar Samy Iskandar Publications: Kim Solez Kim Solez Kim Solez Kim Solez Robert Colvin Gloria Gallo Charles Jennette Charles Jennette Charles Alpers Seymour Rosen optional Parmjeet Randhawa Charles Jennette Charles Jennette optional Stephen Bonsib Research: Robert Colvin Cynthia Nast Byron Croker Byron Croker Mark Haas Tito Cavallo * Board of Directors - officers and chairs of standing committees: Terms are for one year except for Secretary/Treasurer - 3 year term (limited to 2 terms), Councillors (3 year term) and Membership Committee (3 year term, staggered with senior member chair). Chair of the Nominating and Awards committee is the Past President. Chair of the Auditing Committee is the Secretary/Treasurer. Membership, Auditing and Nominating & Awards Committees are limited to 3 members. Education & Scientific Meeting Committees must have at least three members. Other committees are at discretion of the President. + Steering Committee of the Renal Pathology Club 1992 . These are the members who oversaw the transition from club to society. Jay Bernstein, M.D., Frank A. Carone, M.D., Arthur H. Cohen, M.D., Robert B. Colvin, M.D., Ramzi Cotran, M.D., Vivette D'Agati, M.D., Gloria R. Gallo, M.D., Gary S. Hill, M.D., J. Charles Jennette, M.D., Michael Kashgarian, M.D., Vivian Pinn-Wiggins, M.D., H.G. Rennke, M.D., Seymour Rosen, M.D., Benjamin Spargo, M.D., Liliane M. Striker, M.D., M.A. Venkatachalam, M.D.
  10. 10. RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS + 1999 2000 2001 2002 2003 2004 Officers * : President: Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast Charles Jennette Vice- President: Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast Charles Jennette Lorraine Racusen Secretary/Treasurer: Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Councillors: Melvin Schwartz Agnes Fogo Cynthia Nast Charles Jennette Lorraine Racusen Jan Bruijn Agnes Fogo Cynthia Nast Charles Jennette Lorraine Racusen Helmet Rennke Steve Bonsib (2-year) Cynthia Nast Charles Jennette Lorraine Racusen Helmut Rennke Jan Bruijn Mark Haas (3-year) Committees * : Membership: Walter Richardson Alex Magil Alex Magil Patrick Walker Glen Markowitz Maria Picken Alex Magil Mark Weiss Mark Weiss Glen Markowitz Ian Roberts Ingeborg Bajema Mark Weiss Suzanne Meleg-Smith Suzanne Meleg-Smith Maria Picken David Howell Zoltan Laszik Nominating Robert Colvin Seymour Rosen Charles Alpers Melvin Schwartz Agnes Fogo Cynthia Nast & Awards: Charles Alpers Patrick Walker Steve Bonsib Steve Bonsib Jan Bruijn Vivette D’Agati Michael Kashgarian Alex Magil Jan Bruijn Jan Bruijn Glen Markowitz Melvin Schwartz Education Arthur Cohen Charles Jennette Tito Cavallo Jan Bruijn Jan Bruijn Steve Bonsib & Scientific: Guillermo Herrera Agnes Fogo Guillermo Herrera Finn Reinholt Mark Haas Laura Barisoni Lorraine Racusen Melvin Schwartz Byron Croker Isaac Stillman Terry Cook Ian Roberts Seymour Rosen Training Lorraine Racusen Lorraine Racusen Lorraine Racusen Lorraine Racusen Lorraine Racusen Agnes Fogo Programs: Tibor Nadasdy Michael Kashgarian Michael Kashgarian Mike Kashgarian Surya Seshan Samy Iskandar Regina Verani Fred Silva Hermann-Josef Gröne Hermann-Josef Gröne Franco Ferrario Robert Colvin Hermann-Josef Gröne Auditing: Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Guillermo Herrera Charles Jennette Mary Ann Sens Mark Haas Carrie Phillips Joseph Zhou Randy Hennigar Jan Bruijn Maria Picken Surya Seshan Steve Bonsib Mary Fidler Sally Self Paul Shanley Communications Samy Iskandar Samy Iskandar Samy Iskandar Suzanne Meleg-Smith Suzanne Meleg-Smith Suzanne Meleg-Smith & Publications: Kim Solez Kim Solez Kim Solez Kim Solez Kim Solez Luiz Moura Charles Jennette Helen Liapis Helen Liapis Helen Liapis Helen Liapis Kensuke Joh Parmjeet Randhawa Jan Bruijn Jan Bruijn Stephen Bonsib Research: Cynthia Nast Cynthia Nast James Pullman James Pullman Patrick Walker Patrick Walker Franco Ferrario Franco Ferrario Franco Ferrario Franco Ferrario James Pullman Terry Cook James Pullman James Pullman Tibor Nadasdy Tibor Nadasdy Peter Furness Mark Haas
  11. 11. RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS 2003 2004 Program Committee Steve Bonsib Sharan Singh (begun in 2003) Helmut Rennke Surya Seshan Laura Barisoni Volker Nickeleit Lois Arend Kenneth Bernstein
  12. 12. RENAL PATHOLOGY SOCIETY OFFICERS AND COMMITTEE MEMBERS 2005 President: Lorraine Racusen Vice- President: Jan Bruijn Secretary/Treasurer: Guillermo Herrera Councillors: Steve Bonsib Mark Haas Surya Seshan Committees * : Membership: Maria Picken Ingeborg Bajema Zoltan Laszik Nominating Charles Jennette & Awards: Michael Hughson Arthur Abt Education Ian Roberts & Scientific: Laura Barisoni Steve Bonsib Training Agnes Fogo Programs: Robert Colvin Samy Iskandar Research: Pat Walker Serena Bagnasco Terry Cook Mark Haas Carrie Phillips Auditing: Luan Truong Shamila Mauiyyedi Regina Verani Communications Suzanne Meleg- Smith & Publications: Peter Furness Kensuke Joh Luiz Moura Jean Olson Program Committee Volker Nickeleit (begun in 2003) Charles Alpers Jan Bruijn Hermann-Josef Grone
  13. 13. Speakers and Topics of Renal Pathology Club Sponsored Sessions Date Moderator (s) Session Topic Speakers Titles 11/19/78 Michael Kashgarian, M.D. Idiopathic Nephrotic Syndrome With Jay Bernstein, M.D. A Report from the International Study of Kidney "Nil" Disease, Minimal Changes, Focal Disease in Children Segmental or Global Glomerulosclerosis Michael Kashgarian, M.D. Clinical-Pathologic Correlations Peter Burkholder, M.D. Evidence for Immunologic Mechanisms Alfred Michael, M.D. Experimental Models 11/18/79 Ramzi S. Cotran, M.D. Renee Habib, M.D. New Classification of Glomerulonephritis Robert T. McCluskey, M.D. Rapidly Progressive Glomerulonephritis William Couser, M.D. Immunologic Spectrum of RPGN Curtis Wilson, M.D. Studies on Anti-GBM Antibodies & Nephrotoxic Antigens Robert Atkins, M.D. Macrophages in Crescentic GN 11/23/80 Jacob Churg, M.D. The Kidney in Dysproteinemias Liliane Morel-Maroger, M.D. The Pleomorphic Renal Pathology in "Myeloma" Conrad L. Pirani, M.D. and Other Dysproteinemias Fred G. Silva, M.D. Ultrastructural Glomerular and Tubular Lesions in Plasma Cell Dyscrasias Thomas Maack, M.D. Renal Handling of Light Chain and Other Low Molecular Weight Proteins David Clyne, M.D. Experimental Models of "Myeloma" Kidney 11/22/81 Ramzi S. Cotran, M.D. Endothelium, Hemostasis and Intra-vascular Michael A. Gimbrone, Jr., M.D. Basic Biology of the Endothelium Robert H. Heptinstall, M.D. Coagulation in the Kidney Giuseppe Remuzzi, M.D. Regulation of Platelet-Vessel Wall Interactions Jacob Churg, M.D. Coagulation Processes in Renal Glomerulus Robert H. Heptinstall, M.D. Relations of Intravascular Coagulation and Endothelial Damage to Hypertension 12/12/82 Frank A. Carone, M.D. Renal Cystic Disease Jared Grantham, M.D. Pathophysiology of Human Cystic Disease Frank A. Carone, M.D. Tubular Cell and Basement Membrane Changes in Experimental Cystic Disease Andrew P. Evan, M.D. Epithelial Hyperplasia in the Pathogenesis of Renal Cystic Disease 12/15/85 Benjamin H. Spargo, M.D. Pathology of Renal Transplantation Robert B. Colvin, M.D. Mechanisms of Graft Rejection: Phenotype and Function of Infiltrating Cells
  14. 14. Richard K. Sibley, M.D Renal Allograft Histo- and Immunopathology in Cyclosporine Treated Recipients Byron P. Croker, M.D., Ph.D. Glomerulonephritis in Renal Allografts 12/7/86 Liliane J. Striker, M.D. Diabetic Kidney Disease Bryan Myers, M.D. Relationship Between Structure and Function in Human Diabetes Peter Bennett, M.D. Epidemiology of Diabetic Nephropathy in the Pima Indian Population Helmut Rennke, M.D. Nature of Progression of Glomerular Lesions in Diabetic Rats - Relationship with Human Disease Conrad Pirani, M.D. The Basement Membrane in Diabetic Nephropathy 12/13/87 Frank A. Carone, M.D. Current Concepts in the Pathogenesis of Frank A. Carone, M.D. Role of Epithelial Cell in PKD Polycystic Kidney Disease (PKD) Yashpal Kanwar, M.D., Ph.D. Role of Tubular Basement Membrane in PKD James McAteer, Ph.D. Factors Controlling Cyst Growth Kenneth D. Gardner, Jr., M.D. Environmental Factors in PKD 12/11/88 Seymour Rosen, M.D. Vasculitis: Current Concepts Jacob Churg, M.D. Historical Overview J. Charles Jennette, M.D. Crescentic Necrotizing Glomerulonephritis without Immune Complexes: An Expression of Vasculitis C.M. Lockwood, M.D. Anti-Neutrophil Cytoplasmic Antibodies Ramzi S. Cotran, M.D. Pathogenesis of Vasculitis 12/3/89 Michael Kashgarian, M.D. Glomerular Mesangial Disease David H. Lovett, M.D. Pathobiology of Glomerular Mesangium Steven Emancipator, M.D. IgA Nephropathy Melvin M. Schwartz, M.D. Role of Mesangium in Glomerular Sclerosis Jean L. Olson, M.D. Hypertension and Glomerular Sclerosis 12/2/90 Jay Bernstein, M.D. Membranous Glomerulonephritis Giuseppe Andres, M.D. Pathogenesis, an Overview Revisited Seymour Rosen, M.D. Morphologic Evolution Richard J. Glassock, M.D. Clinical Update 3/17/91 Michael Kashgarian, M.D. Current Topics in Renal Pathology J. Charles Jennette, M.D. Anti-Neutrophil Cytoplasmic Autoantibodies Fred Silva, M.D. Arthur Cohen, M.D. HIV and the Kidney Robert Colvin, M.D. Recent Advances in the Pathogenesis of Renal Allograft Rejection Barbara Bane, M.D. Renal Cell Carcinoma: Review and Update 11/17/91 Vivette D'Agati, M.D. Symposium on Cyclosporine Toxicity Michael Mihatsch, M.D. Morphologic Features of Cyclosporine Nephrotoxicity Giuseppe Remuzzi, M.D. Pathogenesis of Cyclosporine Nephrotoxicity William Bennett, M.D. Clinical Update of Cyclosporine Nephrotoxicity
  15. 15. Date Moderator (s) Session Topic Speakers Titles 3/15/92 Jay Bernstein, M.D. Current Topics in Renal Transplantation, Cynthia C. Nast, M.D. Renal Allograft Evaluation by Aspiration Biopsy Tumors, Vascular Disease and Wilm's Tumor and Nephroblastomatosis Glomerulonephritis J. Bruce Beckwith, M.D. Hemolytic-Uremic Syndrome Vivette D'Agati, M.D. Lupus Nephritis: The Results of the Lupus Melvin M. Schwartz, M.D. Collaborative Trial 11/15/92 Arthur Cohen, M.D. Focal Segmental Glomerulosclerosis Gary S. Hill, M.D. Pathology of FSGS Agnes Fogo, M.D. The Pathogenesis of FSGS Stephen Korbet, M.D. The Clinical Management of FSGS 3/14/93 Melvin M. Schwartz, M.D. Current Topics in Glomerular Diseases Gloria Gallo, M.D. Non-amyloid Fibrillary Glomerulopathies and Transplantation Nancy L. Harris, M.D. Post-transplant Lymphoproliferative Disorders Michael E. Lamm, M.D. Update on IgA Nephropathy Jay Bernstein, M.D. Glomerulocystic Disease 11/14/93 Robert Colvin, M.D. Hemolytic-Uremic Syndrome Vivette D'Agati, M.D. Pathology and Pathophysiology Guiseppe Remuzzi, M.D. Clinical Aspects Michael Gimbrone, M.D. Endothelial Biology 3/13/94 Robert Colvin, M.D. Current Topics in Renal Pathology Nancy Harris, M.D. Post-transplant Lymphoproliferative Disorder Kim Solez, M.D. Pathology and Pathogenesis of Acute Tubular Injury Robert McCluskey, M.D. Vasculitis: Pathology and Pathogenesis Charles Alpers, M.D. Cryoglobulinemia and Hepatitis C Virus 10/24/94 Charles Alpers, M.D. Familial Renal Disease Arthur Cohen, M.D. The Renal Basement Membranopathies Billy Hudson, Ph.D. Type IV Collagen: Molecular Structure and Role in Glomerular Disease Stephen Reeders, M.D. Cloning of the Alport's and Polycystic Kidney Disease Genes: Clinical Aspects 3/12/95 Charles Alpers, M.D. Pathobiology of the Tubules and InterstitiumMichael Kashgarian, M.D. Current Concepts in Acute Renal Failure Alison A. Eddy, M.D. Mechanisms of Tubulointerstitial Injury and Fibrosis Fred Silva, M.D. Tubular Cell Proliferation in Health and Disease 11/5/95 Vivette D'Agati, M.D. The Kidney in Hypertension Leopoldo Raij, M.D. Pathobiology of the Vascular Wall in Hypertension Theodore Kurtz, M.D. New Genetic Models of Experimental Hypertension Jean Olson, M.D. Renal Pathology of Hypertension: a Classical
  16. 16. Date Moderator (s) Session Topic Speakers Titles View Remodeled 3/24/96 Arthur Cohen, M.D. Advanced Renal Disease and Renal Mark Weiss, M.D. Acquired Renal Cystic Disease and End-Stage Transplantation Kidneys Fred Sanfilippo, M.D. Current Concepts in Transplant Immunology and Pathobiology Richard K. Sibley, M.D. Pathology of the Transplanted Kidney: Update on Rejection and Classification Schemes Stephen Bonsib, M.D. Recurrent Diseases in the Transplanted Kidney 11/3/96 Agnes Fogo, M.D. Diabetic Nephropathy Kumar Sharma, M.D. Mechanisms Underling Diabetic Nephropathy Liliane Striker, M.D. Renal Pathology of Diabetes Hans-Henrik Parving, M.D. Clinical Aspects of Diabetic Nephropathy 3/2/97 Agnes Fogo, M.D. New Approaches to Renal Biopsy Cynthia Nast, M.D. Fine Needle Aspiration in Diagnosis of Renal Diagnosis and Prognosis Diseases Richard E. Tracy, M.D. Renal Vasculopathies of Essential Hypertension - New Insights and Challenges Lorraine Racusen, M.D. Molecular Markers in Acute Renal Failure Wayne Hancock, M.D. New Approaches in Renal Pathology: Transcriptional Factors, Functional Surface Molecules and Cytokine Products in Inflammatory and Immunologic Injuries 11/2/97 Cynthia C. Nast, M.D. Chronic Allograft Rejection Leendert C. Paul, M.D. Pathogenetic Considerations Hallgrimur Benediktsson, M.D. Pathologic Features Bertram L. Kasiske, M.D. Clinical Aspects, Risk Factors, and Therapy 3/1/98 Cynthia C. Nast, M.D. Viruses and the Kidney Tibor Nadasdy, M.D. Epstein-Barr Virus Sylvana M. Tuur-Saunders (Co-sponsor with Binford-Dammin Sherif R. Zaki, M.D. Hemorrhagic Diseases Society) Roger Smith, M.D. CMV and BK Virus Marshall S. Horowitz, M.D. Adenovirus Immunoregulatory Genes and Their Role in Islet-cell Transplantation, Autoimmunity and Viral Vector Design 10/25/98 Helmut Rennke, M.D. Advances in the Pathobiology of Acute Richard Zager, M.D. The Multifactorial Nature of Acute Renal Failure: Renal Failure The Lessons Learnt from Rhabdomyolysis Seymour Rosen, M.D. Models of Acute Tubular Necrosis: A Perspective Manjeri Venkatachalam, M.D. Cell Biology and Molecular Mechanisms of Tubular Injury 3/21/99 Seymour Rosen, M.D. New Perspectives in Kidney Diseases John Eble, M.D. The Importance of the Classification of Renal Neoplasms
  17. 17. Vivette D’Agati, M.D. The Nature of Nil Disease, Focal Glomerulosclerosis, and Collapsing Glomerulopathy Helmut G. Rennke, M.D. Thin Glomerular Basement Membrane Disease J. Charles Jennette, M.D. Insights into Systemic Vasculitis 11/6/99 Arthur Cohen, M.D. Antineutrophil Cytoplasmic Antibodies J. Charles Jennette, M.D. Serologic and Pathologic Diseases of ANCA- (ANCA) in Renal Disease: Is It Important Associated Renal Diseases Pathogenically or Is It an Epiphenomenon? Caroline O.S. Savage, M.D. Pathogenesis of ANCA-Related Renal Injury John L. Niles, M.D. Utility of ANCA in Long-Term Management and in the Transplant Setting 3/26/00 Arthur Cohen, M.D. Disorders Affecting the Kidney and Liver Wayne Grody, M.D. The Genetics of Autosomal Dominant Polycystic Stephen A. Geller, M.D. Together Kidney Disease Stephen A. Geller, M.D. Ductal Plate Disorders of the Liver Glen S. Markowitz, M.D. New Animal Models of Autosomal Dominant Polycystic Kidney Disease 10/14/00 J. Charles Jennette, M.D. Lupus Nephritis: Pathogenesis, Pathology, Michael Madaio, M.D. Pathogenesis of Lupus Nephritis: Therapeutic Surya Seshan, M.D. and Optimal Therapy Implications Vivette D’Agati, M.D. Pathologic Characterization and Classification of Lupus Nephritis Edmund Lewis, M.D. Clinical Management of Lupus Nephritis: Impact of Pathologic Findings 3/4/01 J. Charles Jennette, M.D. Advances in Renal Pathology and Gary Hill, M.D. The Pathology of Lupus Nephritis: New Insights Pathophysiology Joseph P. Grande, M.D. Omega-3 Fatty Acids: Effects on the Pathogenesis and Progression of Glomerulonephritis Helen Liapis, M.D. Molecular Pathogenesis of Renal Fibrosis Andrey Shaw, M.D. New Insights into Glomerular Podocyte Biology and Pathophysiology 10/14/01 Tito Cavallo, M.D. Renal AL-amyloidogenesis: New insights Guillermo A. Herrera, M.D. Understanding the Pathogenesis of Renal AL- Mark Haas, M.D. into Mechanisms and Therapy amyloidosis Raymond L. Comenzo, M.D. The tropism of organ involvement in AL- amyloidosis 2/24/02 Tito Cavallo, M.D. Hereditary Nephropathies William L. Clapp, M.D. Introduction to Hereditary Nephropathies Byron Croker, M.D. Billy G. Hudson, M.D. Molecular Basis of Alport’s Syndrome: Organization, Assembly and Defects in Type IV Collagen Clifford E. Kashtan, M.D. Alport’s Syndrome and Thin Basement Membrane Nephropathy: Genes, Proteins and Clinico-pathologic Correlations Paul S. Thorner, M.D. Alport’s Syndrome: Prospect for Gene Therapy 11/4/02 William Couser, M.D. New Approaches in the Treatment of Andrew J. Rees, M.D. Macrophages in Renal Inflammation Roger C. Wiggins, M.D. Crescentic Glomerulonephritis Raghu Kalluri, Ph.D. Role of Novel Glomerular Basement Membrane
  18. 18. Antigens in Glomerulonephritis Peter G. Tipping, M.D. Cell-Mediated Aspects of Crescentic Glomerulonephritis: Contributions of Leukocytes and Intrinsic Renal Cells Charles D. Pusey, FRCP Therapies for Crescentic Glomerulonephritis 3/23/03 Stephen Bonsib, M.D. Tubulo-Interstitial Nephritis: Diagnostic John Tomaszewski, M.D. Acute Interstitial Nephritis: Infection, Rejection, Issues, Mechanisms, and Methodologies and Autoimmune Glen Markowitz, M.D. Drug-Induced Tubulointerstitial Nephropathies: New Insights and Old Concepts Dr. Jeffery Kopp Tubular Epithelial Cell Injury and Interstitial Fibrosis Dr. Robert Star New Methods to Diagnose Kidney Disease: Lasers, Chips, & Dendrimers and Beyond 11/15/03 Stephen Bonsib, M.D. An SLE Update: Clinicopathologic J. Charles Jennette, M.D. New Concepts in the Classification of SLE Surya Seshan, M.D. Correlations Nephritis: Pathological Aspects Lee A. Hebert, M.D. Clinical Implications from the Reclassification of the Kidney Biopsy in SLE Howard A. Austin, M.D. SLE Nephritis in Different Clinical Populations: Therapeutic and Prognostic Considerations 3/7/04 Sharan K. Singh, M.D. Update on Renal Transplant Pathology Volker Nickeleit, M.D. The Importance of Routinely Evaluating C4d in Renal Allograft Biopsy Specimens Robert B. Colvin, M.D. New Insights on Chronic Allograft Nephropathy/ Chronic Rejection Lorraine C. Racusen, M.D. Practical Update on the Pathologic Classification of Renal Transplant Pathology Including Criteria for Antibody Mediated Rejection Neeraja Kambham, M.D. Gene Microarray Analysis of Acute Renal Allograft Rejection 10/29/04 Robert B. Colvin, M.D. Donor Pretreatment and Protocol Biopsies Lorraine C. Racusen, M.D. New Markers of Rejection Harsharan K. Singh, M.D. of Kidney Allografts: A Critical Update Volker Nickeleit, M.D., Ph.D. Baseline (Zero Hour) Biopsies David N. Rush, M.D. Protocol Biopsies and Follow-up Biopsies: A Debate – Pro Alan H. Wilkinson, M.D. Protocol Biopsies and Follow-up Biopsies: A Debate – Con 2/27/05 Luan D. Truong, M.D. Pathobiology of the Podocyte Peter Mundel, M.D. Novel Insight Into the Pathogenesis of Nephrotic Syndrome Vivette D’Agati, M.D. Primary and Secondary Focal Segmental Glomerulosclerosis: Morphologic Classification and Clinical Correlation Laura Barisoni, M.D. Modulation of Podocyte Phenotype and the Emerging Role of Biomarkers in Podocytopathies Agnes B. Fogo, M.D. Progression and Potential Regression of
  19. 19. Glomerulosclerosis

×